Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.01

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.01. Revenue for the quarter came in at $9.9 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Wolfe Research sees CNH stock flat 2027 outlook on commodity prices
• Cytek faces $56M damages award in Beckman Coulter patent case